Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Henry Schein Inc Market Cap
The Henry Schein Inc (HSIC) share price is expected to decrease by 3.05% over the next year. This is based on calculating the average 12-month share price estimate provided by 6 stock analysts who have covered HSIC. Price targets range from $65.00 at the low end to $82.00 at the high end. The current analyst consensus for HSIC is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
Henry Schein Inc has a total of 6 Wall St Analyst ratings. There are 3 buy ratings, 1 ratings, and 2 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Henry Schein Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| jonathan block Stifel Nicolaus | Buy | $80.0 | maintained | Jan 26, 2024 |
| jason bednar Piper Sandler | Buy | $78.0 | rated | Jan 17, 2024 |
| allen lutz Bank of America Securities | Sell | $65.0 | maintained | Dec 20, 2023 |
| erin wright Morgan Stanley | Sell | $65.0 | maintained | Dec 20, 2023 |
| nathan rich Goldman Sachs | Hold | $70.0 | maintained | Dec 12, 2023 |
| john stansel J.P. Morgan | Buy | $82.0 | upgraded | Dec 12, 2023 |
| jeff johnson Robert W. Baird | Hold | $76.0 | maintained | Nov 14, 2023 |
| michael petusky Barrington | Buy | $82.0 | maintained | Nov 14, 2023 |
| lisa gill J.P. Morgan | Hold | $69.0 | initiatedcoverage | Nov 10, 2023 |
| rachel vatnsdal J.P. Morgan | Hold | $83.0 | maintained | Aug 9, 2023 |
| michael cherny Bank of America Securities | Sell | $75.0 | reiterated | Aug 7, 2023 |
| kevin caliendo UBS | Hold | $82.0 | maintained | Mar 6, 2023 |
| jonathan yong Credit Suisse | Buy | $97.0 | maintained | Feb 28, 2023 |
| elizabeth anderson cfa Evercore ISI | Hold | $84.0 | maintained | Feb 17, 2023 |
| a.j. rice Credit Suisse | Buy | $90.0 | maintained | Aug 3, 2022 |
| brandon couillard Jefferies | Hold | $88.0 | maintained | May 4, 2022 |
| matt miksic Credit Suisse | Buy | $100.0 | maintained | Feb 16, 2022 |
| michael minchak J.P. Morgan | Hold | $86.0 | maintained | Feb 16, 2022 |
| steven valiquette Barclays | Hold | $82.0 | maintained | Aug 4, 2021 |
| glen santangelo Jefferies | Buy | $75.0 | maintained | Nov 12, 2019 |
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
When did it IPO
1995
Staff Count
24,000
Country
United States
Sector/Industry
Healthcare/Medical Distribution
CEO
Mr. Stanley M. Bergman
Market Cap
$9.83B
In 2023, HSIC generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that HSIC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
$15.24
PCTY-USD
$177.39
EWBC-USD
$70.91
CFLT-USD
$33.84
MTCH-USD
$37.59
ETSY-USD
$77.13
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
